iBio
IBIO
13 hedge funds and large institutions have $234K invested in iBio in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
0% more funds holding
Funds holding: 13 → 13 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
12% less capital invested
Capital invested by funds: $267K → $234K (-$33K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WS
Wedbush Securities
Los Angeles,
California
|
+$16.2K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$4.44K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.63K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$3.23K |
| 5 |
BlackRock
New York
|
+$404 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$5.25K |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$404 |
IBIO Hedge Fund Activity: Q2 2019 in Review
13 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q2 2019, worth a combined $234K — down 12% from $267K a quarter earlier.
Fund positioning in IBIO was balanced in Q2 2019: 1 fund opened new positions, 1 closed out, 4 added to existing stakes and 2 trimmed.
The largest buyer was Wedbush Securities, opening a new position worth an estimated $16.2K. The largest seller was Virtu Financial, cutting an estimated $5.25K.
- 13 institutional investors held iBio (IBIO) as of Q2 2019, unchanged from Q1 2019.
- Funds reported $234K of iBio stock for Q2 2019, down 12% quarter-over-quarter.
- 1 fund opened new iBio positions in Q2 2019 and 1 closed out, a net change of 0 holders.
- The largest iBio buyer in Q2 2019 was Wedbush Securities, an estimated $16.2K added.
- The largest iBio seller in Q2 2019 was Virtu Financial, an estimated $5.25K sold.
Based on aggregated 13F filings for Q2 2019.